Dupixent® / Sanofi Genzyme Head on Incredible Success of "Once-in-a-Career" Product
Sanofi’s inflammation drug Dupixent® is driving a substantial percentage of the firm’s sales in 2020,…
Dina Spencer is Community Manager & Digital Editor at PharmaBoardroom. She lives in Madrid and is interested in all things international.
Sanofi’s inflammation drug Dupixent® is driving a substantial percentage of the firm’s sales in 2020,…
With former head David Loew moving to the CEO position at Ipsen, Sanofi appointed French national Thomas Triomphe…
Saudi Arabia is seeing an increased demand for more innovative medical devices and a greater awareness of the…
The South African affiliate of Indian pharma firm Cipla will begin manufacturing and distribution of remdesivir, a…
Swiss giant Roche tops Pharmaceutical Executive’s 2020 list of the world’s biggest pharma companies, up…
With its brand new hub in Shanghai dedicated to research, business development and venture funding, German pharma…
A new report by Novartis looks at how leading talent in the technology industry is increasingly looking to bring…
In the race to develop the world’s first COVID-19 vaccine, Brazil – now one of the world’s…
French firm LFB is targeting the lucrative US market with its hemophilia products and recently received two FDA…
Six Indian pharma and biotech firms have joined the global race to develop a vaccine for COVID-19 with…
Jeremy Farrar, director of the Wellcome Trust, spoke to Financial Times correspondent Vanessa Kortekaas on 25 June…
French pharma giant Sanofi is pivoting its focus to invest more heavily in vaccines with a plan to invest USD 679…